BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead clinical stage product candidates include mecbotamab vedotin (BA3011), ...
Leadership
Jay M. Short Ph.D.Founder
Co-Founder, CEO & Chairman
Eric L. Sievers M.D.
Chief Medical Officer
Christian J. Vasquez CPA
CFO, CAO, Controller & Corporate Secretary
Susie Melody
Senior Vice President of Human Resources
Cathy Chang Ph.D.
Senior Vice President of Research & Development
Gerhard Frey Ph.D.
Senior Vice President of Technology Development
Monica Sullivan
Senior Vice President of Intellectual Property & Contracts
